Osama Hashmi

CEO and Co-Founder Impiricus

Last Reviewed: September 28, 2026

Executive Summary

Osama Hashmi is co-founder and chief executive of Impiricus, an Atlanta company whose AI-driven platform delivers information from pharmaceutical and life sciences companies to healthcare professionals. He is a physician founder: a board-certified dermatologist who served as Chief Resident of Dermatology at Emory University, and who started the company in 2021 while still in training. He was not its first chief executive. For its first years he ran technology and then product while his co-founder, pharmaceutical executive Sandy Donaldson, was CEO; by August 2025 he held the CEO title, as the company grew into one of the faster-growing private companies in the United States.

Career Highlights

• CEO and co-founder of Impiricus, per an August 2025 interview with Pulse 2.0.
• Co-founded Impiricus in early 2021 with Sandy Donaldson, initially as CTO while a dermatology resident at Emory University.
• Chief Product Officer when the company closed a $3 million Series Seed round led by FCA Venture Partners, with Surface Ventures participating, in April 2022.
• Listed as an executive officer and director in the company’s 2022 and 2023 SEC Form D filings.
• Named an ELITE 2025 Disrupter by PM360.
• Impiricus ranked No. 14 on the 2026 Inc. 5000, reporting three-year revenue growth of 11,691 percent.

Professional Journey

Hashmi trained as a dermatologist and completed his residency at Emory University in Atlanta, where he served as Chief Resident of Dermatology. He holds an MD and an MPH. According to Impiricus, he had worked in health technology for years before that, including founding a teledermatology company and a patient engagement platform, though neither is named in the material reviewed.

Impiricus came out of a problem he saw from the physician’s side: doctors receive a volume of pharmaceutical marketing that buries the clinical information they need. He and Sandy Donaldson founded the company in early 2021 at the Advanced Technology Development Center in Atlanta. Local coverage in January 2021 described it as a two-sided marketplace with an AI-enabled concierge for physicians, working with two pharmaceutical companies at the time; Donaldson was CEO and Hashmi, then still a resident, was CTO. By November 2021 the company had ten employees, had moved into Ponce City Market and was raising a seed round.

That round, $3 million led by FCA Venture Partners, closed in April 2022, when the company described Hashmi as Chief Product Officer and co-founder. Its SEC filings from 2022 and 2023 list him as an executive officer and director alongside Donaldson and director Todd Johnson.

By August 2025 Hashmi was chief executive. The company has not published, in anything reviewed here, when that change took place. Under his leadership Impiricus describes its platform as reaching more than a million healthcare professionals and working with the largest pharmaceutical companies, and he leads a council of physicians who advise on how manufacturer education should reach clinicians. In 2026 the company ranked No. 14 on the Inc. 5000 list of fast-growing private companies.

Education

Holds an MD and an MPH, and completed dermatology residency training at Emory University, where he was Chief Resident. The institutions that awarded his MD and MPH were not identified in any source reviewed.